These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8632423)

  • 1. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
    Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
    J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationally designed analogues of tamoxifen with improved calmodulin antagonism.
    Hardcastle IR; Rowlands MG; Houghton J; Parr IB; Potter GA; Jarman M; Edwards KJ; Laughton CA; Trent JO; Neidle S
    J Med Chem; 1995 Jan; 38(2):241-8. PubMed ID: 7830266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.
    Rowlands MG; Grimshaw R; Jarman M; Bouhoute A; Leclercq G
    Biochem Pharmacol; 1997 Jan; 53(2):241-4. PubMed ID: 9037257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxylic acid analogues of tamoxifen: (Z)-2-[p-(1, 2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine. Estrogen receptor affinity and estrogen antagonist effects in MCF-7 cells.
    Kraft KS; Ruenitz PC; Bartlett MG
    J Med Chem; 1999 Aug; 42(16):3126-33. PubMed ID: 10447957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens.
    Barrera G; Screpanti I; Paradisi L; Parola M; Ferretti C; Vacca A; Farina A; Dianzani MU; Frati L; Gulino A
    Biochem Pharmacol; 1986 Sep; 35(17):2984-6. PubMed ID: 3017367
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
    Bouhoute A; Leclercq G
    Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues.
    McCague R; Rowlands MG; Grimshaw R; Jarman M
    Biochem Pharmacol; 1994 Oct; 48(7):1355-61. PubMed ID: 7945433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifen.
    O'Brian CA; Ioannides CG; Ward NE; Liskamp RM
    Biopolymers; 1990 Jan; 29(1):97-104. PubMed ID: 2158363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity.
    Rowlands MG; Parr IB; McCague R; Jarman M; Goddard PM
    Biochem Pharmacol; 1990 Jul; 40(2):283-9. PubMed ID: 2165403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity.
    Robertson DW; Katzenellenbogen JA; Hayes JR; Katzenellenbogen BS
    J Med Chem; 1982 Feb; 25(2):167-71. PubMed ID: 7057423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro.
    Jordan VC; Lieberman ME; Cormier E; Koch R; Bagley JR; Ruenitz PC
    Mol Pharmacol; 1984 Sep; 26(2):272-8. PubMed ID: 6482874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of tamoxifen: the role of the basic side-chain. Applications of a whole-cell oestrogen-receptor binding assay to N-oxides and quaternary salts.
    Jarman M; Leung OT; Leclercq G; Devleeschouwer N; Stoessel S; Coombes RC; Skilton RA
    Anticancer Drug Des; 1986 Nov; 1(3):259-68. PubMed ID: 3450298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
    Borgna JL; Scali J
    Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential interaction of antiestrogens with cytosol estrogen receptors.
    Black LJ; Jones CD; Goode RL
    Mol Cell Endocrinol; 1981 Apr; 22(1):95-103. PubMed ID: 7239000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
    Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
    Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies.
    Dickerson R; Keller LH; Safe S
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):287-98. PubMed ID: 8545839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activity.
    Fanidi A; Ahnadi C; Fayard JM; Pageaux JF; Laugier C
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):571-7. PubMed ID: 1314079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of antagonistic activity of tamoxifen by replacement of one N-methyl of its side chain by fluorinated residues.
    Agouridas V; Laïos I; Cleeren A; Kizilian E; Magnier E; Blazejewski JC; Leclercq G
    Bioorg Med Chem; 2006 Nov; 14(22):7531-8. PubMed ID: 16870452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.